Qualified Properties For Secondary Residence Potential

Potential Gross Return: 6.05%

Address: 7 Brawn Place, Calwell ACT 2905 Block-Size: 863 sqm
Block: 28 Section: 703
Type: House House/Building Size: TBC
Bedrooms: 3 Bathrooms: 1
Garaging/Car Spots: 4 EER: 1.0
Unimproved Value (2022): $455,000 (2022) UV Price Ratio: 65%
Sales Method: Auction (2023-02-04) Recommend Purchase Price: 700000
Rates Residential 2022: $2,565* Land Tax Residential 2022: $3,768*
Property Link: https://zango.com.au/sale/7-brawn-place-calwell-act-2905-73412/ Marketing Agent: Sandy Morris
Date Added: 30/01/23

Photos:

Block Details

Block Size: 863 sqm Block Type: Large Block
Zoning: RZ1: SUBURBAN Frontage Approx:
Precinct Code: 7 Brawn Place, Calwell ACT 2905 Precinct Code Download Heritage: N/A
Planning Assessment Report: PAR - 7 Brawn Place, Calwell ACT 2905

 

Suburb information

Median house price (2022): $906,000 Median house rent (2022): $683
Suburb highest price (2022): $1,335,000 Rental vacancy rate (2022): 0.37%
Medium household income (Census 2021): 2460% Income to rent ratio: 28%
Download Suburb Profile: Profile - January 2023

Property Purchase Recommendation Summary

Recommend Purchase Price: $700,000 Estimated Stamp Duty: $23,040
Approx Legal And Building Report Costs: $3,000 Total Purchase Investment: $723,040

Recommended Secondary Residence

Recommended Secondary Residence: https://www.canberragrannyflatbuilders.com.au/design-pages/design-384 Approx Turnkey Build Cost inc GST: $350,000
Downloadable Brochure: Design Brochure - 384 Download Proposal: PAP - 7 Brawn Place, Calwell ACT 2905

 

Potential Rental Income

Rental Income Stratgety: Potential Gross Weekly Rental Income of Existing Property: $600
Potential Gross Weekly Rental Income of Recommended Design: $650 Potential Combined Gross Weekly Income: $1,250
Potential Combined Gross Annual Income: $65,000

Financial Summary

Total Purchase and Build Investment: $1,073,040 Potential Combined Gross Rental Annual Income: $65,000
Potential Gross % Return: 6%

Get Help Securing This Opportunity

Share Opportunity:
Contact Us